June 1, 2020 / 12:12 PM / a month ago

BRIEF-Histogen Says First Patient Dosed In Phase 1B/2A Trial Of HSt 001 For Androgenic Alopecia

June 1 (Reuters) - Histogen Inc:

* HISTOGEN ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B/2A TRIAL OF HST 001 FOR ANDROGENIC ALOPECIA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below